| |
| |
|
| Insider
Information: |
Ricks David A |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
481,225 |
|
|
Indirect Shares
|
144,309 |
|
|
| Direct
Value |
$391,498,098 |
|
|
|
Indirect Value
|
$115,895,638 |
|
|
| Total
Shares |
625,534 |
|
|
| Total
Value |
$507,393,736 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 75.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
President, Chair, and ... |
2024-02-12 |
479,250 |
2024-02-12 |
139,637 |
Premium* |
|
|
Adobe Systems Inc |
ADBE |
Director |
2024-04-17 |
1,975 |
2024-04-17 |
4,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2012-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,748 |
19,632 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2013-02-08 |
4 |
S |
$53.91 |
$161,730 |
D/D |
(3,000) |
26,941 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2014-02-03 |
4 |
AS |
$0.00 |
$0 |
D/D |
(3,086) |
34,084 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-02-04 |
4 |
AS |
$69.99 |
$220,259 |
D/D |
(3,147) |
60,138 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2016-02-01 |
4 |
AS |
$78.36 |
$256,472 |
D/D |
(3,273) |
81,863 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-11-05 |
4/A |
D |
$81.05 |
$316,743 |
D/D |
(3,908) |
61,200 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-11-05 |
4 |
D |
$81.05 |
$318,040 |
D/D |
(3,924) |
61,184 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Chair, and CEO |
• • – |
2023-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,200 |
387,543 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2019-10-25 |
4 |
B |
$108.38 |
$500,174 |
D/D |
4,615 |
157,405 |
2.81 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2016-02-01 |
4 |
D |
$79.10 |
$368,290 |
D/D |
(4,656) |
85,136 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-02-02 |
4 |
AS |
$71.51 |
$341,031 |
D/D |
(4,769) |
63,285 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-02-01 |
4 |
D |
$77.03 |
$372,594 |
D/D |
(4,837) |
104,563 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-11-05 |
4 |
OE |
$56.18 |
$279,215 |
D/D |
4,970 |
65,108 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2020-01-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
190,666 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2019-02-01 |
4 |
D |
$119.86 |
$657,432 |
D/D |
(5,485) |
126,223 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,496 |
110,059 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-02-01 |
4 |
D |
$72.00 |
$427,680 |
D/D |
(5,940) |
68,054 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2012-01-26 |
4 |
A |
$39.44 |
$274,029 |
D/D |
6,948 |
16,884 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Chair, and CEO |
• • – |
2023-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,550 |
440,443 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2018-02-01 |
4 |
D |
$81.45 |
$778,581 |
D/D |
(9,559) |
131,250 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,843 |
89,792 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,244 |
109,400 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2014-01-28 |
4 |
A |
$54.23 |
$560,847 |
D/D |
10,342 |
37,170 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2013-01-25 |
4 |
A |
$53.21 |
$594,569 |
D/D |
11,174 |
29,941 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2018-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,764 |
119,486 |
0 |
- |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
